Annual SG&A
$8.90 M
-$47.81 M-84.30%
31 December 2023
Summary:
TherapeuticsMD annual selling, general & administrative expenses is currently $8.90 million, with the most recent change of -$47.81 million (-84.30%) on 31 December 2023. During the last 3 years, it has fallen by -$185.10 million (-95.41%). TXMD annual SG&A is now -95.41% below its all-time high of $194.01 million, reached on 31 December 2020.TXMD Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.31 M
+$77.00 K+6.24%
30 September 2024
Summary:
TherapeuticsMD quarterly selling, general & administrative expenses is currently $1.31 million, with the most recent change of +$77.00 thousand (+6.24%) on 30 September 2024. Over the past year, it has dropped by -$280.00 thousand (-17.61%). TXMD quarterly SG&A is now -97.76% below its all-time high of $58.44 million, reached on 30 September 2021.TXMD Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$3.80 B
-$3.32 M-0.09%
30 September 2024
Summary:
TherapeuticsMD TTM selling, general & administrative expenses is currently -$3.80 billion, with the most recent change of -$3.32 million (-0.09%) on 30 September 2024. Over the past year, it has dropped by -$3.82 billion (-21504.36%). TXMD TTM SG&A is now -471245.18% below its all-time high of $204.26 million, reached on 30 June 2020.TXMD TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXMD Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -84.3% | -17.6% | -10000.0% |
| 3 y3 years | -95.4% | -97.8% | -1982.1% |
| 5 y5 years | -92.3% | -97.1% | -2525.9% |
TXMD Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -95.4% | at low | -97.8% | +101.8% | -1.0% | +8.5% |
| 5 y | 5 years | -95.4% | at low | -97.8% | +101.8% | -62.7% | +8.5% |
| alltime | all time | -95.4% | >+9999.0% | -97.8% | +101.8% | <-9999.0% | +8.5% |
TherapeuticsMD Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.31 M(+6.2%) | $5.34 M(-5.0%) |
| June 2024 | - | $1.23 M(-6.7%) | $5.62 M(-21.6%) |
| Mar 2024 | - | $1.32 M(-10.4%) | $7.17 M(-19.5%) |
| Dec 2023 | $8.90 M(-84.3%) | $1.48 M(-7.2%) | $8.90 M(-49.9%) |
| Sept 2023 | - | $1.59 M(-42.8%) | $17.77 M(-41.6%) |
| June 2023 | - | $2.78 M(-9.0%) | $30.43 M(-27.9%) |
| Mar 2023 | - | $3.06 M(-70.5%) | $42.22 M(-25.6%) |
| Dec 2022 | $56.71 M(-29.8%) | $10.34 M(-27.4%) | $56.71 M(-320.1%) |
| Sept 2022 | - | $14.25 M(-2.3%) | -$25.77 M(-239.9%) |
| June 2022 | - | $14.57 M(-16.9%) | $18.43 M(-67.0%) |
| Mar 2022 | - | $17.55 M(-124.3%) | $55.89 M(-30.8%) |
| Dec 2021 | $80.75 M(-58.4%) | -$72.14 M(-223.4%) | $80.75 M(-60.0%) |
| Sept 2021 | - | $58.44 M(+12.3%) | $202.09 M(+10.6%) |
| June 2021 | - | $52.04 M(+22.7%) | $182.66 M(+1.9%) |
| Mar 2021 | - | $42.41 M(-13.8%) | $179.22 M(-7.6%) |
| Dec 2020 | $194.01 M(+11.0%) | $49.21 M(+26.1%) | $194.01 M(-2.1%) |
| Sept 2020 | - | $39.01 M(-19.7%) | $198.14 M(-3.0%) |
| June 2020 | - | $48.60 M(-15.0%) | $204.26 M(+3.7%) |
| Mar 2020 | - | $57.19 M(+7.2%) | $197.05 M(+12.8%) |
| Dec 2019 | $174.72 M(+50.6%) | $53.35 M(+18.2%) | $174.73 M(+11.4%) |
| Sept 2019 | - | $45.13 M(+9.0%) | $156.79 M(+10.4%) |
| June 2019 | - | $41.39 M(+18.7%) | $142.02 M(+9.2%) |
| Mar 2019 | - | $34.86 M(-1.5%) | $130.10 M(+12.2%) |
| Dec 2018 | $115.99 M(+101.0%) | $35.41 M(+16.7%) | $115.99 M(+22.4%) |
| Sept 2018 | - | $30.35 M(+3.0%) | $94.76 M(+23.9%) |
| June 2018 | - | $29.47 M(+42.0%) | $76.46 M(+24.1%) |
| Mar 2018 | - | $20.76 M(+46.4%) | $61.62 M(+6.8%) |
| Dec 2017 | $57.70 M(+12.4%) | $14.18 M(+17.6%) | $57.70 M(-3.6%) |
| Sept 2017 | - | $12.06 M(-17.6%) | $59.85 M(-4.3%) |
| June 2017 | - | $14.63 M(-13.1%) | $62.52 M(+6.9%) |
| Mar 2017 | - | $16.84 M(+3.1%) | $58.51 M(+13.9%) |
| Dec 2016 | $51.35 M(+78.8%) | $16.33 M(+10.9%) | $51.35 M(+17.6%) |
| Sept 2016 | - | $14.72 M(+38.6%) | $43.65 M(+21.3%) |
| June 2016 | - | $10.62 M(+9.7%) | $35.99 M(+11.6%) |
| Mar 2016 | - | $9.68 M(+12.1%) | $32.24 M(+12.2%) |
| Dec 2015 | $28.72 M(+29.8%) | $8.63 M(+22.2%) | $28.72 M(+12.2%) |
| Sept 2015 | - | $7.06 M(+2.8%) | $25.60 M(+4.1%) |
| June 2015 | - | $6.87 M(+11.4%) | $24.59 M(+5.7%) |
| Mar 2015 | - | $6.16 M(+11.8%) | $23.26 M(+5.1%) |
| Dec 2014 | $22.12 M(+16.4%) | $5.51 M(-8.8%) | $22.12 M(+4.5%) |
| Sept 2014 | - | $6.04 M(+9.1%) | $21.17 M(+6.5%) |
| June 2014 | - | $5.54 M(+10.1%) | $19.88 M(+0.3%) |
| Mar 2014 | - | $5.03 M(+10.3%) | $19.82 M(+2.6%) |
| Dec 2013 | $19.01 M(+35.1%) | $4.56 M(-4.1%) | $19.31 M(-1.9%) |
| Sept 2013 | - | $4.75 M(-13.2%) | $19.69 M(+10.2%) |
| June 2013 | - | $5.48 M(+21.0%) | $17.86 M(+11.9%) |
| Mar 2013 | - | $4.53 M(-8.2%) | $15.95 M(+11.9%) |
| Dec 2012 | $14.07 M(+119.6%) | $4.93 M(+68.6%) | $14.25 M(+19.7%) |
| Sept 2012 | - | $2.92 M(-18.2%) | $11.91 M(+12.1%) |
| June 2012 | - | $3.57 M(+26.4%) | $10.62 M(+28.8%) |
| Mar 2012 | - | $2.83 M(+9.3%) | $8.25 M(+28.8%) |
| Dec 2011 | $6.41 M | $2.59 M(+58.4%) | $6.41 M(-8.7%) |
| Sept 2011 | - | $1.63 M(+36.1%) | $7.02 M(+28.7%) |
| June 2011 | - | $1.20 M(+21.9%) | $5.45 M(+26.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | $985.10 K(-69.2%) | $4.32 M(+24.7%) |
| Dec 2010 | $3.46 M(+125.4%) | $3.20 M(+4685.1%) | $3.46 M(+327.5%) |
| Sept 2010 | - | $66.90 K(+0.3%) | $810.50 K(-25.9%) |
| June 2010 | - | $66.70 K(-48.7%) | $1.09 M(+5.0%) |
| Mar 2010 | - | $130.00 K(-76.2%) | $1.04 M(+10.7%) |
| Dec 2009 | $1.54 M(+288.5%) | $546.90 K(+55.9%) | $941.00 K(+133.7%) |
| Sept 2009 | - | $350.90 K(+2371.1%) | $402.60 K(+310.0%) |
| June 2009 | - | $14.20 K(-51.0%) | $98.20 K(-74.8%) |
| Mar 2009 | - | $29.00 K(+241.2%) | $389.50 K(-1.5%) |
| Dec 2008 | $395.60 K(+322.2%) | $8500.00(-81.7%) | $395.60 K(-3.8%) |
| Sept 2008 | - | $46.50 K(-84.8%) | $411.20 K(+4.5%) |
| June 2008 | - | $305.50 K(+770.4%) | $393.50 K(+261.0%) |
| Mar 2008 | - | $35.10 K(+45.6%) | $109.00 K(+16.5%) |
| Dec 2007 | $93.70 K(-30.7%) | $24.10 K(-16.3%) | $93.60 K(+260.0%) |
| Sept 2007 | - | $28.80 K(+37.1%) | $26.00 K(-50.6%) |
| June 2007 | - | $21.00 K(+6.6%) | $52.60 K(-30.4%) |
| Mar 2007 | - | $19.70 K(-145.3%) | $75.60 K(-44.7%) |
| Dec 2006 | $135.20 K(-49.6%) | -$43.50 K(-178.5%) | $136.60 K(-52.6%) |
| Sept 2006 | - | $55.40 K(+25.9%) | $288.00 K(+3.0%) |
| June 2006 | - | $44.00 K(-45.5%) | $279.60 K(-5.5%) |
| Mar 2006 | - | $80.70 K(-25.2%) | $295.80 K(+10.2%) |
| Dec 2005 | $268.40 K(+40.5%) | $107.90 K(+129.6%) | $268.40 K(+18.4%) |
| Sept 2005 | - | $47.00 K(-21.9%) | $226.60 K(+3.9%) |
| June 2005 | - | $60.20 K(+12.9%) | $218.10 K(+12.8%) |
| Mar 2005 | - | $53.30 K(-19.4%) | $193.40 K(+1.3%) |
| Dec 2004 | $191.00 K(+86.9%) | $66.10 K(+71.7%) | $191.00 K(+30.3%) |
| Sept 2004 | - | $38.50 K(+8.5%) | $146.60 K(+12.9%) |
| June 2004 | - | $35.50 K(-30.3%) | $129.90 K(+10.1%) |
| Mar 2004 | - | $50.90 K(+134.6%) | $118.00 K(+9.1%) |
| Dec 2003 | $102.20 K(+22.5%) | $21.70 K(-0.5%) | $108.20 K(+6.4%) |
| Sept 2003 | - | $21.80 K(-7.6%) | $101.70 K(-1.1%) |
| June 2003 | - | $23.60 K(-42.6%) | $102.80 K(+1.8%) |
| Mar 2003 | - | $41.10 K(+170.4%) | $101.00 K(+21.2%) |
| Dec 2002 | $83.40 K(-6.7%) | $15.20 K(-33.6%) | $83.30 K(-10.6%) |
| Sept 2002 | - | $22.90 K(+5.0%) | $93.20 K(+2.4%) |
| June 2002 | - | $21.80 K(-6.8%) | $91.00 K(+1.7%) |
| Mar 2002 | - | $23.40 K(-6.8%) | $89.50 K(+0.1%) |
| Dec 2001 | $89.40 K(+3.1%) | $25.10 K(+21.3%) | $89.40 K(+24.0%) |
| Sept 2001 | - | $20.70 K(+2.0%) | $72.10 K(-3.5%) |
| June 2001 | - | $20.30 K(-12.9%) | $74.70 K(-8.2%) |
| Mar 2001 | - | $23.30 K(+198.7%) | $81.40 K(-6.2%) |
| Dec 2000 | $86.70 K(+26.9%) | $7800.00(-66.5%) | $86.80 K(+6.4%) |
| Sept 2000 | - | $23.30 K(-13.7%) | $81.60 K(+2.9%) |
| June 2000 | - | $27.00 K(-5.9%) | $79.30 K(+10.4%) |
| Mar 2000 | - | $28.70 K(+1003.8%) | $71.80 K(+12.5%) |
| Dec 1999 | $68.30 K(-27.9%) | $2600.00(-87.6%) | $63.80 K(+4.2%) |
| Sept 1999 | - | $21.00 K(+7.7%) | $61.20 K(+52.2%) |
| June 1999 | - | $19.50 K(-5.8%) | $40.20 K(+94.2%) |
| Mar 1999 | - | $20.70 K | $20.70 K |
| Dec 1998 | $94.70 K(-2.1%) | - | - |
| Dec 1997 | $96.70 K(+6.9%) | - | - |
| Dec 1996 | $90.50 K(+8.4%) | - | - |
| Dec 1995 | $83.50 K(+1.1%) | - | - |
| Dec 1994 | $82.60 K(-4.4%) | - | - |
| Dec 1993 | $86.40 K | - | - |
FAQ
- What is TherapeuticsMD annual selling, general & administrative expenses?
- What is the all time high annual SG&A for TherapeuticsMD?
- What is TherapeuticsMD annual SG&A year-on-year change?
- What is TherapeuticsMD quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for TherapeuticsMD?
- What is TherapeuticsMD quarterly SG&A year-on-year change?
- What is TherapeuticsMD TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for TherapeuticsMD?
- What is TherapeuticsMD TTM SG&A year-on-year change?
What is TherapeuticsMD annual selling, general & administrative expenses?
The current annual SG&A of TXMD is $8.90 M
What is the all time high annual SG&A for TherapeuticsMD?
TherapeuticsMD all-time high annual selling, general & administrative expenses is $194.01 M
What is TherapeuticsMD annual SG&A year-on-year change?
Over the past year, TXMD annual selling, general & administrative expenses has changed by -$47.81 M (-84.30%)
What is TherapeuticsMD quarterly selling, general & administrative expenses?
The current quarterly SG&A of TXMD is $1.31 M
What is the all time high quarterly SG&A for TherapeuticsMD?
TherapeuticsMD all-time high quarterly selling, general & administrative expenses is $58.44 M
What is TherapeuticsMD quarterly SG&A year-on-year change?
Over the past year, TXMD quarterly selling, general & administrative expenses has changed by -$280.00 K (-17.61%)
What is TherapeuticsMD TTM selling, general & administrative expenses?
The current TTM SG&A of TXMD is -$3.80 B
What is the all time high TTM SG&A for TherapeuticsMD?
TherapeuticsMD all-time high TTM selling, general & administrative expenses is $204.26 M
What is TherapeuticsMD TTM SG&A year-on-year change?
Over the past year, TXMD TTM selling, general & administrative expenses has changed by -$3.82 B (-21504.36%)